Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement
08 févr. 2022 17h27 HE
|
Telix Pharmaceuticals Limited
MELBOURNE and LIEGE, Belgium, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a global clinical supply agreement with Berlin-based...
FDA Approves Phase II Kidney Cancer Therapy Study
13 sept. 2021 18h41 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug...
Telix and Merck to Commence Pan-Cancer Clinical Combination Studies
17 août 2021 21h03 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has entered into a pan-cancer clinical collaboration...
Telix and Merck KGaA, Darmstadt, Germany, to Commence Pan-Cancer Clinical Combination Studies
17 août 2021 21h02 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has entered into a pan-cancer clinical collaboration...
Telixが日本で腎臓がん用画像診断薬の臨床治験を開始
29 août 2019 20h00 HE
|
Telix Pharmaceuticals Limited
メルボルン, オーストラリア および京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
29 août 2019 20h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging
14 oct. 2018 18h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
Telix Pharmaceuticals, University of Melbourne and Peter Mac to Collaborate on Colorectal Cancer
23 août 2018 19h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”) has today announced a research collaboration with the University of Melbourne...
Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market
15 août 2018 19h00 HE
|
Telix Pharmaceuticals Limited; Nihon Medi-Physics Co., Ltd.
MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...
Telix Pharmaceuticals and JFE Progress Japanese Manufacturing Partnership
25 juil. 2018 19h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and TOKYO, July 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development...